XML 38 R19.htm IDEA: XBRL DOCUMENT
v3.19.1

Postretirement Health Care and Life Insurance Benefits | 12 Months Ended
--- | ---
Feb. 02, 2019
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract] |
Postretirement Health Care and Life Insurance Benefits | Postretirement Health Care and Life Insurance Benefits In addition to pension and other supplemental benefits, certain retired employees currently are provided with specified health care and life insurance benefits. Eligibility requirements for such benefits vary by division and subsidiary, but generally state that benefits are available to eligible employees who were hired prior to a certain date and retire after a certain age with specified years of service. Certain employees are subject to having such benefits modified or terminated. The following provides a reconciliation of benefit obligations, plan assets, and funded status of the postretirement obligations as of February 2, 2019 and February 3, 2018:
| 2018 |  | 2017
| (millions)
Change in accumulated postretirement benefit obligation |  |  |
Accumulated postretirement benefit obligation, beginning of year | $ | 156 |  |  | $ | 186 |
Service cost | — |  |  | — |
Interest cost | 5 |  |  | 5 |
Plan amendment | — |  |  | (10 | )
Actuarial gain | (11 | ) |  | (9 | )
Medicare Part D subsidy | — |  |  | 1 |
Benefits paid | (13 | ) |  | (17 | )
Accumulated postretirement benefit obligation, end of year | 137 |  |  | 156 |
Change in plan assets |  |  |
Fair value of plan assets, beginning of year | — |  |  | — |
Company contributions | 13 |  |  | 17 |
Benefits paid | (13 | ) |  | (17 | )
Fair value of plan assets, end of year | — |  |  | — |
Funded status at end of year | $ | (137 | ) |  | $ | (156 | )
Amounts recognized in the Consolidated Balance Sheets at February 2, 2019 and February 3, 2018 |  |  |
Accounts payable and accrued liabilities | $ | (15 | ) |  | $ | (17 | )
Other liabilities | (122 | ) |  | (139 | )
| $ | (137 | ) |  | $ | (156 | )
Amounts recognized in accumulated other comprehensive loss at February 2, 2019 and February 3, 2018 |  |  |
Net actuarial gain | $ | (41 | ) |  | $ | (35 | )
Prior service credit | (9 | ) |  | (10 | )
| $ | (50 | ) |  | $ | (45 | )
Net postretirement benefit costs and other amounts recognized in other comprehensive loss included the following actuarially determined components:
| 2018 |  | 2017 |  | 2016
| (millions)
Net Periodic Postretirement Benefit Cost |  |  |  |  |
Service cost | $ | — |  |  | $ | — |  |  | $ | — |
Interest cost | 5 |  |  | 5 |  |  | 6 |
Amortization of net actuarial gain | (5 | ) |  | (5 | ) |  | (4 | )
Amortization of prior service credit | (1 | ) |  | — |  |  | — |
| (1 | ) |  | — |  |  | 2 |
Other Changes in Plan Assets and Projected Benefit Obligation Recognized in Other Comprehensive Loss |  |  |  |  |
Net actuarial gain | (11 | ) |  | (9 | ) |  | (13 | )
Amortization of net actuarial gain | 5 |  |  | 5 |  |  | 4 |
Amortization of prior service credit | 1 |  |  | — |  |  | — |
Prior service credit | — |  |  | (10 | ) |  | — |
| (5 | ) |  | (14 | ) |  | (9 | )
Total recognized | $ | (6 | ) |  | $ | (14 | ) |  | $ | (7 | )
The estimated net actuarial gain and prior service credit that will be amortized from accumulated other comprehensive loss into net periodic postretirement benefit cost during 2019 is $7 million. The following weighted average assumption was used to determine the accumulated postretirement benefit obligations at February 2, 2019 and February 3, 2018:
| 2018 |  | 2017
Discount rate | 4.02 | % |  | 3.71 | %
The following weighted average assumption was used to determine the net postretirement benefit costs for the postretirement obligations:
| 2018 |  | 2017 |  | 2016
Discount rate used to measure interest cost | 3.28 | % |  | 3.17 | % |  | 3.14 | %
The accumulated postretirement benefit obligation assumptions are evaluated annually, and at interim re-measurements if required, and updated as necessary. The discount rate used to determine the present value of the Company’s accumulated postretirement benefit obligations is based on a yield curve constructed from a portfolio of high quality corporate debt securities with various maturities. Each year’s expected future benefit payments are discounted to their present value at the appropriate yield curve rate, thereby generating the overall discount rate for the accumulated postretirement benefit obligations. The Company estimates the interest cost component of net periodic benefit costs using a full yield curve approach in the estimation of these components of net periodic benefit costs. Under this approach, the Company applies discounting using individual spot rates from the yield curve composed of the rates of return from a portfolio of high quality corporate debt securities available at the measurement date. These spot rates align to each of the projected benefit obligation and service cost cash flows. The future medical benefits provided by the Company for certain employees are based on a fixed amount per year of service, and the accumulated postretirement benefit obligation is not affected by increases in health care costs. However, the future medical benefits provided by the Company for certain other employees are affected by increases in health care costs. The following provides the assumed health care cost trend rates related to the Company’s accumulated postretirement benefit obligations at February 2, 2019 and February 3, 2018:
| 2018 |  | 2017
Health care cost trend rates assumed for next year | 5.38% - 9.31% |  | 5.50% - 10.50%
Rates to which the cost trend rate is assumed to decline (the ultimate trend rate) | 4.5% |  | 4.5%
Year that the rate reaches the ultimate trend rate | 2027 |  | 2027
The assumed health care cost trend rates have an impact on the amounts reported for the accumulated postretirement benefit obligations. A one-percentage-point change in the assumed health care cost trend rates would have the following effects:
| 1 – Percentage Point Increase |  | 1 – Percentage Point Decrease
| (millions)
Effect on total of service and interest cost | $ | — |  |  | $ | — |
Effect on accumulated postretirement benefit obligations | $ | 7 |  |  | $ | (6 | )
The following table reflects the benefit payments estimated to be funded by the Company and paid from the accumulated postretirement benefit obligations and estimated federal subsidies expected to be received under the Medicare Prescription Drug Improvement and Modernization Act of 2003:
| Expected Benefit Payments |  | Expected Federal Subsidy
| (millions)
Fiscal Year |  |  |
2019 | $ | 15 |  |  | $ | — |
2020 | 14 |  |  | — |
2021 | 13 |  |  | — |
2022 | 13 |  |  | — |
2023 | 12 |  |  | — |
2024-2028 | 47 |  |  | 1 |

X
- References No definition available. + Details
Name: | us-gaap_PensionAndOtherPostretirementBenefitExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for postemployment benefits, which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement. Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 712 -URI http://asc.fasb.org/topic&trid=2197446 + Details
Name: | us-gaap_PostemploymentBenefitsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration